Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 4,681 | 9,142 | 9,552 | 10,264 | 4,444 |
| Cost of Goods | 1,580 | 11,030 | 3,030 | 1,770 | 880 |
| Gross Profit | 3,090 | -1,880 | 6,520 | 8,480 | 3,560 |
| Operating Expenses | 7,160 | 13,030 | 7,280 | 6,820 | 5,290 |
| Operating Income | -3,479 | -14,888 | -728 | 2,444 | -846 |
| Interest Expense | 70 | -10 | 150 | 420 | 610 |
| Other Income | 199 | 938 | 548 | 426 | -24 |
| Pre-tax Income | -3,350 | -13,940 | -330 | 2,450 | -1,480 |
| Income Tax | 310 | -1,520 | 190 | 890 | -260 |
| Net Income Continuous | -2,795 | -8,948 | -298 | 1,561 | -307 |
| Net Income | $-2,795 | $-8,948 | $-298 | $1,561 | $-307 |
| EPS Basic Total Ops | -0.05 | -0.17 | -0.01 | 0.02 | -0.01 |
| EPS Basic Continuous Ops | -0.05 | -0.17 | -0.01 | 0.03 | -0.01 |
| EPS Diluted Total Ops | -0.05 | -0.17 | -0.01 | 0.02 | -0.01 |
| EPS Diluted Continuous Ops | -0.05 | -0.17 | -0.01 | 0.03 | -0.01 |
| EBITDA(a) | $-3,479 | $-13,438 | $172 | $3,434 | $44 |